The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 04, 2014
Filed:
Oct. 11, 2010
Applicants:
Stuart D. Shanler, Pomona, NY (US);
Andrew Ondo, Las Cruces, NM (US);
Inventors:
Stuart D. Shanler, Pomona, NY (US);
Andrew Ondo, Las Cruces, NM (US);
Assignee:
Allergan, Inc., Irvine, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/50 (2006.01); A61K 31/415 (2006.01); A01N 33/02 (2006.01); A61K 31/135 (2006.01); C07D 233/00 (2006.01); C07D 233/02 (2006.01); A61Q 19/00 (2006.01); A61Q 19/02 (2006.01); A61K 8/49 (2006.01); A61K 45/06 (2006.01); A61K 31/4174 (2006.01); A61K 31/137 (2006.01); A61K 31/4164 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4174 (2013.01); A61Q 19/004 (2013.01); A61Q 19/02 (2013.01); A61K 8/4946 (2013.01); A61K 45/06 (2013.01); A61K 31/137 (2013.01); A61K 2800/70 (2013.01); A61Q 19/00 (2013.01); A61K 31/4164 (2013.01);
Abstract
The present invention is directed to the treatment of skin erythema as exhibited in rosacea and other conditions characterized by increased erythema (redness) of the skin. These conditions exhibit dilation of blood vessels due to a cutaneous vascular hyper-reactivity. In particular, the present invention is directed to a novel composition and method for the treatment of skin erythema using α-adrenergic receptor (α-adrenoceptor) agonists incorporated into cosmetic, pharmacological or dermatological compositions for topical application to the skin.